featured
Progression of Retinopathy With GLP1 Receptor Agonists With Cardiovascular Benefits in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Diabetes and its Complications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis
J Diabetes Complicat 2022 Jul 05;[EPub Ahead of Print], Y Yoshida, P Joshi, S Barri, J Wang, AL Corder, SS O'Connell, VA FonsecaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.